The M&A Advisor awarded Elliott Greenleaf the 13th annual Turnaround Award for health care/life sciences deal of the year under $500 million.

Elliott Greenleaf received the award for having served as co-counsel to the committee of unsecured creditors in Orexigen Therapeutics Inc., according to a press release from the firm.

The award is set to be presented at a gala as part of the 2019 Distressed Investing Summit, scheduled for March 27 and 28.